Ahead

Ahead provides an online telepsychiatry platform that focuses on providing psychiatric care for adults with Attention Deficit Hypertension Disorder (ADHD), depression, and anxiety through a network of board-certified psychiatrists and psychiatric nurse practitioners. The company also has physical clinics and employs full-time healthcare providers—unlike most telepsychiatry platforms that contract providers.

Ahead’s treatment plan includes medication, tailored counseling, and lifestyle coaching. Patients take part in a free online assessment, followed by a 50-minute evaluation session with a psychiatrist to determine an appropriate treatment plan, and follow-up consultations to track their progress. The company charges a total appointment fee of USD 225, for the initial session, USD 160 for short (20-25 minutes) follow-up sessions, and USD 275 for long (45-50 minutes) follow-up sessions. Ahead ships prescribed medication directly to patients for free through its partnership with Truepill—an investor in Ahead—and also allows prescription renewal through their patient portal. 

Ahead was founded in 2019 with a focus on treating ADHD and later expanded its services to include treatments for anxiety and depression along with traditional therapy. Services are currently available in 9 states. In July 2020, Ahead raised USD 9 million in a corporate funding round.